000 01606 a2200421 4500
005 20250513111533.0
264 0 _c19970225
008 199702s 0 0 eng d
022 _a0025-7125
024 7 _a10.1016/s0025-7125(05)70509-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetri, M
245 0 0 _aPathogenesis and treatment of the antiphospholipid antibody syndrome.
_h[electronic resource]
260 _bThe Medical clinics of North America
_cJan 1997
300 _a151-77 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAbortion, Habitual
_xetiology
650 0 4 _aAntibodies, Anticardiolipin
_xanalysis
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAntiphospholipid Syndrome
_xdrug therapy
650 0 4 _aApolipoproteins
_xanalysis
650 0 4 _aEndothelium, Vascular
_xphysiology
650 0 4 _aFemale
650 0 4 _aGlycoproteins
_xanalysis
650 0 4 _aHumans
650 0 4 _aLupus Coagulation Inhibitor
_xanalysis
650 0 4 _aPlatelet Aggregation
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdrug therapy
650 0 4 _aProtein C
_xphysiology
650 0 4 _aThrombocytopenia
_xetiology
650 0 4 _aThrombophlebitis
_xetiology
650 0 4 _aThrombosis
_xetiology
650 0 4 _aWarfarin
_xtherapeutic use
650 0 4 _abeta 2-Glycoprotein I
773 0 _tThe Medical clinics of North America
_gvol. 81
_gno. 1
_gp. 151-77
856 4 0 _uhttps://doi.org/10.1016/s0025-7125(05)70509-5
_zAvailable from publisher's website
999 _c9003675
_d9003675